Please note: AABB reserves the right to make updates to this program.
Live Program Date: Tuesday, November 6, 2018 -
Master Program Number: 18EL-377 (see program format numbers below under Registration)
Educational Track: Technical/Clinical
Topic: Transfusion Medicine (Hemovigilance)
Intended Audience: Physicians, Technologists, Nurses, Managers/Supervisors, Laboratory Staff, Medical Directors, Students/Fellows, Residents
Teaching Level: Intermediate
Moderator: Deanna Fang, MD, HLA Director in Training, Department of Pathology & Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA
Speakers: Jo Wiersum, MD, Transfusion and Transplantation Reactions in Patients (TRIP), Netherlands; Srijana Rajbhandary, BDS, MPH, Research and Data Analyst, AABB, Bethesda, MD
After participating in this educational activity, participants should be able to:
- Explain what a Patient Safety Organization is and why it is able to protect hospital data.
- Describe the use of hemovigilance data to improve patient safety in the US.
- Describe the use of hemovigilance data to improve patient safety internationally through the knowledge shared by a hemovigilance expert from the Transfusion and Transplantation Reactions in Patients (TRIP), Netherlands.
This program will explore how hemovigilance data are used to improve transfusion patient safety in the US and in the Netherlands. Material will explain what a Patient Safety Organization (PSO) is and why AABB established its PSO in 2008. There will be a discussion of the CDC NHSN Hemovigilance Module and how data are reported and shared with the AABB PSO.
| || ||
|Single Viewer: On-Demand||
|Group Viewing: On-Demand||
Continuing Education Credit
AABB designates both the live and on-demand version of this eCast each to be eligible for 1.0 continuing education credit/contact hour for Physicians, California Nurse, California Lab Personnel, Florida Lab Personnel and General Participation credit. The final number of credit(s) and credit types awarded for this program (live or on-demand) was determined by the program duration. For more information on each credit type please visit our
Continuing Education Credits webpage.
Srijana Rajbhandary, BDS, MPH, Research and Data Analyst at AABB has been working in the field of hemovigilance research since 2014. She completed her degree in Bachelor of Dental Surgery (BDS) from Nepal in 2009 and degree in Master of Public Health in Epidemiology from Emory University, Atlanta, USA in 2013. She has been working closely with both US and international hemovigilance experts for various AABB projects. In her current role, she oversees the AABB Patient Safety Organizations- AABB Center for Patient Safety activities as well as various other research projects. She has represented AABB Department of Research at various stages and authored various reports and publications.
Dr. Jo Wiersum obtained her medical degree in Leiden in 1981 and went on to work in the UK and the Republic of Guinea (West Africa). Since 1996 she has worked as a donor physician for the Dutch blood supply organisation, Sanquin. In 2000 she completed specialty training in community medicine. Since 2002 when the Dutch national hemovigilance office TRIP started, she has been its national medical coordinator. TRIP stands for Transfusion and Transplantation Reactions in Patients because it also handles reports on tissue and cell vigilance. Jo has chaired of the International Society for Blood Transfusion haemovigilance working party since 2011. In 2013 she obtained a PhD in medicine on a thesis entitled Hemovigilance: is it making a difference to safety in the transfusion chain.